Clinical Trials Directory

Trials / Unknown

UnknownNCT06248541

The Effect of Low-Level Laser Therapy in Carpal Tunnel Syndrome

The Effect of Low-Level Laser Therapy in Carpal Tunnel Syndrome: A Randomized, Single-Blinded, Placebo-Controlled Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Medical University of Graz · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Carpal tunnel syndrome (CTS) is a chronic compression of the median nerve, which can lead to symptoms such as nocturnal pain and paresthesia in the area innervated by the median nerve. The affected patients also describe discomfort and hypoesthesia in the nerve supply area. Due to the COVID (Coronavirus disease) pandemic, CTS operations have been postponed and delayed. A promising and safe alternative for improving CTS-related symptoms appears to be non-invasive, non-thermal low-level-laser therapy. As a possible conservative, alternative method, low-level-laser therapy has the potential to enable patients with CTS to improve their disease-related symptoms or at least to alleviate the symptoms until the indicated CTS operation (carpal tunnel release). The aim of this randomized, single-blind, placebo-controlled clinical trial is to investigate the influence of 3 weeks of low-level-laser therapy on the symptoms typical of CTS in patients with surgery-indicated carpal tunnel syndrome and its influence on quality of life.

Conditions

Interventions

TypeNameDescription
DEVICEtreatment with low-level laser therapylow-level laser therapy (wavelength of 620 - 640nm)
DEVICEtreatment with conventional light diodesconventional light diodes

Timeline

Start date
2023-08-03
Primary completion
2025-09-30
Completion
2025-12-31
First posted
2024-02-08
Last updated
2024-02-08

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT06248541. Inclusion in this directory is not an endorsement.